Sabah Saad
Department of Oncology
Monash Health
Australia
Biography
Monash Health is Victoria’s largest public health service. We are proud to provide healthcare to one quarter of Melbourne’s population, across the entire life-span from newborn and children, to adults, the elderly, their families and carers. We improve the health of our community through: Prevention and early intervention Community-based treatment and rehabilitation Highly specialised surgical and medical diagnosis, treatment and monitoring services Hospital and community-based mental health services Comprehensive sub-acute, aged care and palliative care programs Research, education and teaching the next generation of healthcare professionals Regional and state-wide specialist services More than 16,000 staff work at over 40 care locations across south eastern Melbourne, including Monash Medical Centre, Monash Children’s Hospital, Moorabbin Hospital, Dandenong Hospital, Casey Hospital, Kingston Centre, Cranbourne Centre, and an extensive network of rehabilitation, aged care, community health and mental health facilities.
Research Interest
Sabah is an Ethics Submission Specialist (ESS) at Cancer Trials Australia with expertise in both start-up and post approvals. As an ESS, Sabah is responsible for facilitating the submission of primary, accepting and single-site oncology clinical trials through the Streamlined Ethical Review Process (SERP). Previously, Sabah was in a similar role at Clinical Trial Cancer Centre at Austin Health (2016), a Clinical Research Coordinator (CRC) at the Western Health (2015) and Nucleus Network – Centre for Clinical Studies (2012-2014). Encompassing 6 years’ experience in the line of work, Sabah retains a strong emphasis and dedication to perfecting her skills and techniques and prides herself on her competency in the field. The greater part of her work with Nucleus has been with Phase 1 clinical research – performing clinical procedures, trial setup and research operations. In addition to her roles above, she has completed a GCP course in 2012 specifically, ACRP: Good Clinical Practice for Research Professionals which has enabled her to work in adherence to GCP guidelines. Her experience in Clinical Trials has expanded and broadened her knowledge in drug action, drug development and provided understanding of local and international ICH-GCP guidelines.